NEW ENTERPRISE ASSOCIATES 13 LP Insider Trading $CLVS Clovis Oncology, Inc.
Get free email notifications about insider trading for NEW ENTERPRISE ASSOCIATES 13 LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NEW ENTERPRISE ASSOCIATES 13 LP. NEW ENTERPRISE ASSOCIATES 13 LP is 10% Owner in PhaseBio Pharmaceuticals Inc ($PHAS) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Cloudflare, Inc. ($NET) and 10% Owner in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Dermira, Inc. ($DERM) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
NEW ENTERPRISE ASSOCIATES 13 LP in Clovis Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NEW ENTERPRISE ASSOCIATES 13 LP: 10% Owner
Holdings: 2,279,781 shares
Current Value: $136,786,860
Latest Transaction: Jun 05 2013
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NEW ENTERPRISE ASSOCIATES 13 LP in Clovis Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HIVE, BOX, CRCM, NET, CLVS, CVT, DERM, EPZM, GLYC, MM, OMTH, PHAS, RARX, RYTM, ROKA, SPT, TSRO, WDAY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2013 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Sell | J | 0.00 | 1,139,890 | 0 | 2,279,781 | 3.4 M to 2.3 M (-33.33 %) |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 377,124 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 2,612,330 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 1,206,897 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 1,186,897 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 13.00 | 1,316,299 | 17,111,887 | 3,419,671 | 2.1 M to 3.4 M (+62.58 %) |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 377,124 | 0 | 2,103,372 | 1.7 M to 2.1 M (+21.85 %) |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 1,726,248 | 0 | 1,726,248 | 0 to 1.7 M |
Page: 1